Press Room

The following statement can be attributed to Andrew Schepers, director of government relations in Michigan for the American Cancer Society Cancer Action Network.

Lansing, MI – May 16, 2019 – The following statement can be attributed to Andrew Schepers, director of government relations in Michigan for the American Cancer Society Cancer Action Network.

LANSING, Mich.– April 24, 2019 – Nearly 130 cancer patients, survivors and caregivers from across the state traveled to the Capitol in Lansing today to meet with Michigan’s lawmakers.

Lansing, MI – March 20, 2019 – Today, the American Cancer Society Cancer Action Network, American Heart Association and the American Lung Association mark Kick Butts Day by calling on Michigan’s lawmakers to reduce the toll of tobacco on Michiganders.

Lansing, MI – January 14, 2019 – As lawmakers dive into the new year, the American Cancer Society Cancer Action Network (ACS CAN) is asking that legislators support legislation that will ease the burden of cancer in Michigan.

Today, the American Cancer Society Cancer Action Network urged lawmakers to do better when it comes to tobacco prevention and cessation funding.

Olivet, Mich. – September 24, 2018 – CJ Heisler was awarded ACT! Lead of the Year by the American Cancer Society Cancer Action Network (ACS CAN) for her exceptional commitment to advocacy work to help make cancer a national priority. 

Lansing, MI – August 9, 2019 – Michigan is falling short when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer according to the latest edition of How Do You Measure Up?: A Progress Report on State Legislative Activity

LANSING, Mich.– May 2, 2018 – The American Cancer Society Cancer Action Network (ACS CAN), gave testimony today to express their concerns about legislation that has been passed by the Michigan Senate and is being considered by the House Appropriations Committee.

The Michigan Senate today voted in favor of a bill to ensure oral chemotherapy is not subject to higher out-of-pocket costs than intravenous chemotherapy. It now moves to the House of Representatives for further consideration.